Developer docs
API playgroundTry for free, no card

Search company profiles

Vytrus Biotech

Full company profile

uuid00031mi

Namestring
Vytrus Biotech
Legal namestring
VYTRUS BIOTECH S.A.
Websiteurl
vytrus.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Vytrus Biotech is a Barcelona-based plant biotechnology company founded in 2008 as a spin-off from the University of Barcelona's Faculty of Pharmacy. It develops and manufactures high-value natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology, operating as a B2B ingredient supplier to cosmetic manufacturers, personal care brands, and formulation companies worldwide.

The company's technology stack is anchored by six proprietary biotechnological platforms: Plant Cell Biofactories, Plasma Rich in Cell Factors (PRCF), Phyto-Peptidic Fractions (PPF), Phyto-Lipidic Fractions (PLF), Phyto-Glucidic Fractions (PGF), and Phyto-Cell Fusions (PCF), with the newer Precision Biofactories™ platform extending into recombinant protein production. Using plant stem cells as biofactories, these platforms produce differentiated bioactive outputs including plant exosomes, peptides, lipid RAFTs, glycoconjugates, and biomimetic proteins. The portfolio comprises 19 commercial active ingredients spanning anti-aging, skin regeneration, microbiome modulation, hair care, neurocosmetic, and sun protection applications. The company holds two US patents covering wound healing applications for Clarivine™ and Centella Reversa™ and has been recognized with multiple industry innovation awards including Best Innovation at in-cosmetics Global 2025.

Vytrus generates revenue by selling ingredients through an international distributor network spanning 52+ countries, with no publicly disclosed price points (B2B quote-based pricing). The company reports €5.9 million in full-year 2025 sales and €6.0 million in H1 2026 (+37% YoY), with a stated 2027 revenue target of €12 million. Capital structure includes a €2.3 million Boyser-led round in May 2024, a €2 million ICF debt facility in January 2026, and listing on BME Growth (Spain's alternative market). A €3.5 million investment in a new Terrassa production plant will triple manufacturing capacity. The company holds EcoVadis Gold (2026) and Platinum (2025) sustainability ratings.

Short descriptiontext

Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and sells natural active cosmetic ingredients derived from plant stem cells to B2B cosmetic manufacturers and formulation houses across 52+ countries via its proprietary biotech platform portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTerrassa, Spain
HQ citystring
Terrassa
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plant stem cell biotechnology, cosmetic active ingredients, natural personal care actives, skincare ingredient manufacturing, biotechnology cosmetic ingredients
Industry1 code
SECONDARYEUAAAIAK
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Cosmetic Active Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Active Cosmetic Ingredients B2B Sales
TypeOne Time License
Description

Vytrus Biotech generates revenue by developing and selling natural active ingredients derived from plant stem cells to cosmetic manufacturers, formulation companies, and personal care brands. The company commercializes 16+ cosmetic ingredients through its international distributor network spanning 52+ countries. Revenue comes from ingredient sales to B2B customers in the cosmetics industry.

vytrus.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Precision Biofactories™
Description

A platform for identifying the optimal combination of highly active proteins and biological matrices to produce them, combining biotechnology, diverse expression systems, and deep knowledge of biochemistry and biological communication.

vytrus.com
Core offering1 text field

Vytrus Biotech develops, manufactures, and sells natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology. The company produces 19+ branded cosmetic actives (Toleroxyl™, Clarivine™, Capilia Longa™, Centella Reversa™, and others) targeting skin care, hair care, sun care, anti-aging, microbiome modulation, and neurocosmetic applications. Production occurs at industrial scale through seven in-house biotechnological platforms and is commercialized worldwide via an international distributor network covering more than 52 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 32% sales growth in Q1 2024
+4 more records
Product overview1 text field

Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and manufactures high-value natural active ingredients for the cosmetics industry on an industrial scale. The company offers a portfolio of 19 distinct cosmetic active ingredients (Toleroxyl™, Ignilyte™, Clarivine™, Baolift™, Photobiome™, Quora Noni™ biomics, Elaya Renova™, Nectaria Lithops™, Deobiome Noni™, Kannabia Sense™, Olea Vitae™, Sarcoslim Re-Shape™, Quora Noni™, Turmeria Zen™, Capilia Longa™, Centella Reversa™, Sensia Carota™, Luminia Granatum™, Arabian Cotton™) based on five proprietary biotechnological platforms: Plant Cell Biofactories, Plasma Rich in Cell Factors (PRCF), Phyto-Peptidic Fractions™ (PPF), Phyto-Lipidic Fractions (PLF), Phyto-Glucidic Fractions (PGF), Phyto-Cell Fusions (PCF), and the newer Precision Biofactories™ platform for recombinant proteins. The products leverage plant stem cell technology to deliver regenerative, anti-aging, microbiome-modulating, and neurocosmetic benefits for skin and hair care applications.

Product and service16 records
1Toleroxyl™
CategoryCosmetic Active Ingredients
Description

Biotech active ingredient designed to treat sensitive and urban skin by re-educating hyperreactive urban skin; the first product of Vytrus's Precision Biofactories™ recombinant protein platform. Sold B2B to cosmetic manufacturers and formulators.

2Ignilyte™
CategoryCosmetic Active Ingredients
Description

Bioelectric cosmetic active that reactivates skin bioelectrical pathways and mimics device-based electrostimulation naturally; sold B2B to cosmetic formulators.

3Clarivine™
CategoryCosmetic Active Ingredients
Description

Cosmetic active derived from Vitis vinifera (grapevine) stem cell cultures using exosomic resveratrol, delivering a fasting-mimicking effect on skin for glass skin and longevity applications. Award-winning ingredient covered by US patents for wound healing.

4Baolift™
CategoryCosmetic Active Ingredients
Description

Skin workout cosmetic active providing a V-lifting effect by training skin for improved firmness and elasticity; sold B2B to cosmetic formulators.

5Photobiome™
CategoryCosmetic Active Ingredients
Description

Microbial antioxidant cosmetic active that protects skin microbiota from photo-damage and fights microbial-induced photoageing; sold B2B to cosmetic formulators.

6Quora Noni™ biomics
CategoryCosmetic Active Ingredients
Description

Microbiota-focused cosmetic active that rebalances skin microbiota for anti-aging effects including skin firming and perfecting; sold B2B to cosmetic formulators.

7Elaya Renova™
CategoryCosmetic Active Ingredients
Description

Hair care cosmetic active that boosts scalp anchoring, hydration, regeneration, and protection; provides hair restructuring and reinforcing benefits; sold B2B to cosmetic formulators.

8Nectaria Lithops™
CategoryCosmetic Active Ingredients
Description

Vitamin D-enriched cosmetic active (cell nectar for D-skin) delivering dewy, deeply hydrated skin; sold B2B to cosmetic formulators.

9Deobiome Noni™
CategoryCosmetic Active Ingredients
Description

Biological deodorant cosmetic active providing global odor intensity reduction, dandruff reduction, and microbiota rebalancing; sold B2B to personal care formulators.

10Kannabia Sense™
CategoryCosmetic Active Ingredients
Description

Neurocosmetic active that activates brain pleasure areas and induces better self-perception and positive emotions via the skin-brain connection; sold B2B to cosmetic formulators.

11Olea Vitae™
CategoryCosmetic Active Ingredients
Description

Anti-aging cosmetic active that revitalizes mature skin by recharging internal cell batteries to tackle energetic ageing; sold B2B to cosmetic formulators.

12Sarcoslim Re-Shape™
CategoryCosmetic Active Ingredients
Description

Skin remodeling cosmetic active for smart and targeted slimming, acting as a liposculture solution for sculpting curves; sold B2B to cosmetic formulators.

13Quora Noni™
CategoryCosmetic Active Ingredients
Description

Microbiome communication cosmetic active that reduces sebum production and rebalances skin microbiota; sold B2B to cosmetic formulators.

14Turmeria Zen™
CategoryCosmetic Active Ingredients
Description

Neurocosmetic active rich in natural plant exosomes with anti-stress wrinkle benefits, modulating brain-skin connection for emotional wellbeing; sold B2B to cosmetic formulators.

15Capilia Longa™
CategoryCosmetic Active Ingredients
Description

Hair density cosmetic active rich in natural plant exosomes and exopeptides, designed to make hair sprout again; sold B2B to hair care formulators.

16Centella Reversa™
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Mibelle Biochemistry
TypeDirect peer
Description

Mibelle Biochemistry is a Swiss manufacturer of cosmetic active ingredients based on plant cell biotechnology and biochemistry. Direct peer due to nearly identical technology platform (plant cells/biotech to produce cosmetic actives) and comparable B2B business model targeting cosmetic formulators.

TypeDirect peer
Description

Provital Group is a Barcelona-based manufacturer of natural active ingredients for cosmetics and personal care, also founded by a team with academic roots. Direct peer sharing geographic home market, B2B model, and botanical active ingredient portfolio, competing for similar formulation customers.

TypeDirect peer
Description

CLR Berlin is a German manufacturer of natural and biotechnology-based active ingredients for the cosmetics industry. Direct peer operating in plant cell cultures and biotech actives at comparable scale to Vytrus, serving the same B2B cosmetic formulator customer base.

TypeDirect peer
Description

Sederma is a French specialist in bioactive cosmetic ingredients including peptides and plant-derived actives, owned by Croda International. Direct peer in peptide/biomimetic cosmetic actives, though now operating with significantly larger parent resources for global distribution.

5Lucas Meyer Cosmetics (IFF)
TypeDirect peer
Description

Lucas Meyer Cosmetics develops phospholipids, peptides, and biotech-derived cosmetic actives, now part of IFF. Direct peer in specialty cosmetic actives with similar technology-forward approach, though benefiting from IFF's global scale.

TypeBroad incumbent
Description

Givaudan Active Beauty is the cosmetic ingredients division of Swiss fragrance giant Givaudan, offering a broad portfolio including biotech actives. Broad incumbent that competes with Vytrus for premium cosmetic brand accounts but operates at much greater scale with diverse technology platforms.

TypeBroad incumbent
Description

DSM-Firmenich is a global specialty ingredients company with personal care actives spanning vitamins, peptides, and biotech-derived ingredients. Broad incumbent with overlapping cosmetic active ingredient portfolio but vastly larger resources and broader end-market exposure including nutrition and pharma.

TypeBroad incumbent
Description

Symrise is a major German flavors and fragrances company with a Diana division that develops natural and biotech-based cosmetic ingredients. Broad incumbent serving similar cosmetic formulator customers but with broader portfolio and significantly larger global footprint.

TypeBroad incumbent
Description

Evonik's Personal Care & Cosmetics business develops specialty ingredients including biotechnology-derived actives for skincare. Broad incumbent with overlapping biotech active ingredients offering but operating within a much larger specialty chemicals portfolio across multiple industries.

TypeBroad incumbent
Description

BASF's Care Creations division supplies cosmetic ingredients including plant-based and biotechnology-derived actives. Broad incumbent competing in the same ingredient supply value chain but with portfolio spanning thousands of ingredients across multiple industries and global scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vytrus Biotech

Cosmetic Active Ingredientsvytrus.com

Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and sells natural active cosmetic ingredients derived from plant stem cells to B2B cosmetic manufacturers and formulation houses across 52+ countries via its proprietary biotech platform portfolio.

What Vytrus Biotech does

Vytrus Biotech is a Barcelona-based plant biotechnology company founded in 2008 as a spin-off from the University of Barcelona's Faculty of Pharmacy. It develops and manufactures high-value natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology, operating as a B2B ingredient supplier to cosmetic manufacturers, personal care brands, and formulation companies worldwide.

The company's technology stack is anchored by six proprietary biotechnological platforms: Plant Cell Biofactories, Plasma Rich in Cell Factors (PRCF), Phyto-Peptidic Fractions (PPF), Phyto-Lipidic Fractions (PLF), Phyto-Glucidic Fractions (PGF), and Phyto-Cell Fusions (PCF), with the newer Precision Biofactories™ platform extending into recombinant protein production. Using plant stem cells as biofactories, these platforms produce differentiated bioactive outputs including plant exosomes, peptides, lipid RAFTs, glycoconjugates, and biomimetic proteins. The portfolio comprises 19 commercial active ingredients spanning anti-aging, skin regeneration, microbiome modulation, hair care, neurocosmetic, and sun protection applications. The company holds two US patents covering wound healing applications for Clarivine™ and Centella Reversa™ and has been recognized with multiple industry innovation awards including Best Innovation at in-cosmetics Global 2025.

Vytrus generates revenue by selling ingredients through an international distributor network spanning 52+ countries, with no publicly disclosed price points (B2B quote-based pricing). The company reports €5.9 million in full-year 2025 sales and €6.0 million in H1 2026 (+37% YoY), with a stated 2027 revenue target of €12 million. Capital structure includes a €2.3 million Boyser-led round in May 2024, a €2 million ICF debt facility in January 2026, and listing on BME Growth (Spain's alternative market). A €3.5 million investment in a new Terrassa production plant will triple manufacturing capacity. The company holds EcoVadis Gold (2026) and Platinum (2025) sustainability ratings.

Vytrus Biotech firmographics

Firmographics
Name
Vytrus Biotech
Legal name
VYTRUS BIOTECH S.A.
Website
https://vytrus.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and sells natural active cosmetic ingredients derived from plant stem cells to B2B cosmetic manufacturers and formulation houses across 52+ countries via its proprietary biotech platform portfolio.
Ownership category
akta.pro rank

Where Vytrus Biotech is headquartered

Location

Headquarters

HQ city
Terrassa
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Vytrus Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Active Cosmetic Ingredients B2B Sales: Vytrus Biotech generates revenue by developing and selling natural active ingredients derived from plant stem cells to cosmetic manufacturers, formulation companies, and personal care brands. The company commercializes 16+ cosmetic ingredients through its international distributor network spanning 52+ countries. Revenue comes from ingredient sales to B2B customers in the cosmetics industry.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Vytrus Biotech product offering

Product offering

Core offering

Vytrus Biotech develops, manufactures, and sells natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology. The company produces 19+ branded cosmetic actives (Toleroxyl™, Clarivine™, Capilia Longa™, Centella Reversa™, and others) targeting skin care, hair care, sun care, anti-aging, microbiome modulation, and neurocosmetic applications. Production occurs at industrial scale through seven in-house biotechnological platforms and is commercialized worldwide via an international distributor network covering more than 52 countries.

Product overview

Vytrus Biotech is a Barcelona-based plant biotechnology company that develops and manufactures high-value natural active ingredients for the cosmetics industry on an industrial scale. The company offers a portfolio of 19 distinct cosmetic active ingredients (Toleroxyl™, Ignilyte™, Clarivine™, Baolift™, Photobiome™, Quora Noni™ biomics, Elaya Renova™, Nectaria Lithops™, Deobiome Noni™, Kannabia Sense™, Olea Vitae™, Sarcoslim Re-Shape™, Quora Noni™, Turmeria Zen™, Capilia Longa™, Centella Reversa™, Sensia Carota™, Luminia Granatum™, Arabian Cotton™) based on five proprietary biotechnological platforms: Plant Cell Biofactories, Plasma Rich in Cell Factors (PRCF), Phyto-Peptidic Fractions™ (PPF), Phyto-Lipidic Fractions (PLF), Phyto-Glucidic Fractions (PGF), Phyto-Cell Fusions (PCF), and the newer Precision Biofactories™ platform for recombinant proteins. The products leverage plant stem cell technology to deliver regenerative, anti-aging, microbiome-modulating, and neurocosmetic benefits for skin and hair care applications.

Differentiator

Problem solved

Functional benefit

Brands

  • Precision Biofactories™: A platform for identifying the optimal combination of highly active proteins and biological matrices to produce them, combining biotechnology, diverse expression systems, and deep knowledge of biochemistry and biological communication.

Products and services

  • Toleroxyl™ Biotech active ingredient designed to treat sensitive and urban skin by re-educating hyperreactive urban skin; the first product of Vytrus's Precision Biofactories™ recombinant protein platform. Sold B2B to cosmetic manufacturers and formulators.
  • Ignilyte™ Bioelectric cosmetic active that reactivates skin bioelectrical pathways and mimics device-based electrostimulation naturally; sold B2B to cosmetic formulators.
  • Clarivine™ Cosmetic active derived from Vitis vinifera (grapevine) stem cell cultures using exosomic resveratrol, delivering a fasting-mimicking effect on skin for glass skin and longevity applications. Award-winning ingredient covered by US patents for wound healing.
  • Baolift™ Skin workout cosmetic active providing a V-lifting effect by training skin for improved firmness and elasticity; sold B2B to cosmetic formulators.
  • Photobiome™ Microbial antioxidant cosmetic active that protects skin microbiota from photo-damage and fights microbial-induced photoageing; sold B2B to cosmetic formulators.
  • Quora Noni™ biomics Microbiota-focused cosmetic active that rebalances skin microbiota for anti-aging effects including skin firming and perfecting; sold B2B to cosmetic formulators.
  • Elaya Renova™ Hair care cosmetic active that boosts scalp anchoring, hydration, regeneration, and protection; provides hair restructuring and reinforcing benefits; sold B2B to cosmetic formulators.
  • Nectaria Lithops™ Vitamin D-enriched cosmetic active (cell nectar for D-skin) delivering dewy, deeply hydrated skin; sold B2B to cosmetic formulators.
  • Deobiome Noni™ Biological deodorant cosmetic active providing global odor intensity reduction, dandruff reduction, and microbiota rebalancing; sold B2B to personal care formulators.
  • Kannabia Sense™ Neurocosmetic active that activates brain pleasure areas and induces better self-perception and positive emotions via the skin-brain connection; sold B2B to cosmetic formulators.
  • Olea Vitae™ Anti-aging cosmetic active that revitalizes mature skin by recharging internal cell batteries to tackle energetic ageing; sold B2B to cosmetic formulators.
  • Sarcoslim Re-Shape™ Skin remodeling cosmetic active for smart and targeted slimming, acting as a liposculture solution for sculpting curves; sold B2B to cosmetic formulators.
  • Quora Noni™ Microbiome communication cosmetic active that reduces sebum production and rebalances skin microbiota; sold B2B to cosmetic formulators.
  • Turmeria Zen™ Neurocosmetic active rich in natural plant exosomes with anti-stress wrinkle benefits, modulating brain-skin connection for emotional wellbeing; sold B2B to cosmetic formulators.
  • Capilia Longa™ Hair density cosmetic active rich in natural plant exosomes and exopeptides, designed to make hair sprout again; sold B2B to hair care formulators.
  • Centella Reversa™

Quantifiable outcome

  • 32% sales growth in Q1 2024
  • +4 more outcomes

Companies that use Vytrus Biotech

Customer profile

Segments2 records

Ideal customer profiles1 record

Vytrus Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Vytrus Biotech partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Vytrus Biotech competitors and assessment

Company assessment

Direct peers

  • Mibelle Biochemistry: Mibelle Biochemistry is a Swiss manufacturer of cosmetic active ingredients based on plant cell biotechnology and biochemistry. Direct peer due to nearly identical technology platform (plant cells/biotech to produce cosmetic actives) and comparable B2B business model targeting cosmetic formulators.
  • Provital Group: Provital Group is a Barcelona-based manufacturer of natural active ingredients for cosmetics and personal care, also founded by a team with academic roots. Direct peer sharing geographic home market, B2B model, and botanical active ingredient portfolio, competing for similar formulation customers.
  • CLR Berlin: CLR Berlin is a German manufacturer of natural and biotechnology-based active ingredients for the cosmetics industry. Direct peer operating in plant cell cultures and biotech actives at comparable scale to Vytrus, serving the same B2B cosmetic formulator customer base.
  • Sederma (Croda): Sederma is a French specialist in bioactive cosmetic ingredients including peptides and plant-derived actives, owned by Croda International. Direct peer in peptide/biomimetic cosmetic actives, though now operating with significantly larger parent resources for global distribution.
  • Lucas Meyer Cosmetics (IFF): Lucas Meyer Cosmetics develops phospholipids, peptides, and biotech-derived cosmetic actives, now part of IFF. Direct peer in specialty cosmetic actives with similar technology-forward approach, though benefiting from IFF's global scale.

Broad incumbents

  • Givaudan Active Beauty: Givaudan Active Beauty is the cosmetic ingredients division of Swiss fragrance giant Givaudan, offering a broad portfolio including biotech actives. Broad incumbent that competes with Vytrus for premium cosmetic brand accounts but operates at much greater scale with diverse technology platforms.
  • DSM-Firmenich: DSM-Firmenich is a global specialty ingredients company with personal care actives spanning vitamins, peptides, and biotech-derived ingredients. Broad incumbent with overlapping cosmetic active ingredient portfolio but vastly larger resources and broader end-market exposure including nutrition and pharma.
  • Symrise Diana Food: Symrise is a major German flavors and fragrances company with a Diana division that develops natural and biotech-based cosmetic ingredients. Broad incumbent serving similar cosmetic formulator customers but with broader portfolio and significantly larger global footprint.
  • Evonik Care Solutions: Evonik's Personal Care & Cosmetics business develops specialty ingredients including biotechnology-derived actives for skincare. Broad incumbent with overlapping biotech active ingredients offering but operating within a much larger specialty chemicals portfolio across multiple industries.
  • BASF Care Creations: BASF's Care Creations division supplies cosmetic ingredients including plant-based and biotechnology-derived actives. Broad incumbent competing in the same ingredient supply value chain but with portfolio spanning thousands of ingredients across multiple industries and global scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

Vytrus Biotech social profiles

Digital presence

Vytrus Biotech compliance and trust

Trust signal

Compliance3 records

Vytrus Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vytrus Biotech leadership team

Management profile

Number of profiles

Profiles1 record

Vytrus Biotech funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vytrus Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vytrus Biotech

What does Vytrus Biotech do?

Vytrus Biotech develops, manufactures, and sells natural active ingredients for the cosmetics industry using proprietary plant stem cell biotechnology. The company produces 19+ branded cosmetic actives (Toleroxyl™, Clarivine™, Capilia Longa™, Centella Reversa™, and others) targeting skin care, hair care, sun care, anti-aging, microbiome modulation, and neurocosmetic applications. Production occurs at industrial scale through seven in-house biotechnological platforms and is commercialized worldwide via an international distributor network covering more than 52 countries.

Is Vytrus Biotech a public or private company?

Vytrus Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was Vytrus Biotech founded?

Vytrus Biotech was founded in 2008. It employs 11 to 50 people.

Where is Vytrus Biotech based?

Vytrus Biotech is headquartered in Terrassa, Spain, in the Europe region.

How does Vytrus Biotech make money?

One revenue line is on record: active Cosmetic Ingredients B2B Sales.

Who are Vytrus Biotech's main competitors?

Direct peers on record are Mibelle Biochemistry, Provital Group, CLR Berlin, Sederma (Croda) and Lucas Meyer Cosmetics (IFF). Broad incumbents are Givaudan Active Beauty, DSM-Firmenich, Symrise Diana Food, Evonik Care Solutions and BASF Care Creations.

Does Vytrus Biotech have an API?

No public API is recorded for Vytrus Biotech.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StDo Vytrus Biotech's (BME:VYT) Earnings Warrant Your Attention?Vytrus Biotech's earnings per share grew 184% year-on-year from €0.14 to €0.39 over the past 12 months, with EBIT margins rising from 16% to 33%. Insiders hold €36m, representing 34% of the company, indicating strong alignment with shareholders.EXPANSIONVytrus Biotech dispara su beneficio en el primer semestre de 2026Vytrus Biotech, a Barcelona-based plant biotechnology company specializing in active ingredients for cosmetics, reported a net profit of 2.5 million euros in the first half of 2026, representing a 73% increase compared to the same period in 2025. Sales reached 6 million euros with 37% growth, while EBITDA climbed to 3.48 million euros (67% increase), positioning the company toward its strategic target of 12 million euros in revenue by 2027. Geographic expansion continued with sales now spanning 52 countries, particularly strong in Latin America (+83%) and the EU (+49%), though the US market declined 14%.Empresas de Capital Riesgo en EspaVytrus Biotech receives a €2M loan from the ICF to set up a new plant in TerrassaVytrus Biotech has secured a €2 million Eurocrèdit loan from the Institut Català de Finances (ICF) to establish a new production plant in Terrassa, Spain. The €3.5 million investment project will enable the biotechnology company to triple its production capacity as part of its strategic growth plan. The ICF Eurocrèdit loan programme offers favourable terms to Catalan SMEs through co-financing from the European Union's European Regional Development Fund.ICF.catVytrus Biotech receives a €2M loan from the ICF to set up a new plant in TerrassaVytrus Biotech has secured a €2 million Eurocrèdit loan from the Institut Català de Finances (ICF) to establish a new production plant in Terrassa. The project represents a €3.5 million total investment and is central to the company's strategic growth plan, with the new facilities expected to triple Vytrus Biotech's production capacity.Cosmetics BusinessFrom seed to fruit - Phyture Biotech becomes Vytrus BiotechPhyture Biotech changed its name to Vytrus Biotech in April, reflecting an expanded focus beyond dermocosmetics into healthcare and nutraceuticals. The new name, inspired by the Latin word 'vita' (life), signals the company's growth and internationalization. It also launched a new website, www.vytrus.com.Cosmetics BusinessVytrus Biotech unveils Capilia Longa – the hair 3D Bio-printerVytrus Biotech unveiled Capilia Longa, a hair growth product based on turmeric callus culture. In vitro tests showed up to 177% dermal papilla cell proliferation and 115% IGF-1 production, while a 40-volunteer trial reported up to 89% hair loss reduction and 52% density increase after 150 days.Cosmetics BusinessVytrus Biotech launches the Crowdfunding campaign Vytrus HairVytrus Biotech launched an Indiegogo crowdfunding campaign for Vytrus Hair, a hair-growth lotion, on July 5th. The campaign reached over 60% of its goal in less than two weeks, with early bird rewards selling out. If the goal is met, production begins in August and shipments start in September.Cosmetics BusinessVytrus Biotech raises over €600,000 through Capital CellVytrus Biotech raised €604,304 through Capital Cell's equity crowdfunding, exceeding its €550,000 goal by 110%. The funds will support industrial growth, research, and preparation for an alternative stock market. The company also ran a successful Indiegogo rewards campaign.Cosmetics BusinessVytrus Biotech launches new skin repairing active ingredientVytrus Biotech launched SARCOSLIM RE-SHAPE PRCF, a plant-based active ingredient for fat reduction and skin firming. In vivo studies showed up to +10% facial elasticity and -18% facial sagging reduction. The ingredient is Ecocert certifiable and targets specific body areas.Cosmetics BusinessVytrus Biotech presents TURMERIA ZEN PRCF for stressed skinVytrus Biotech presents TURMERIA ZEN PRCF, a multi-active ingredient from its Plant Cell Biofactories platform, to counteract stress-induced skin aging. The ingredient is produced sustainably, saving 10,000kg of water per kg compared to traditional turmeric powder.